|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 48, 733-744, March 2007
Control of matrix effects in the analysis of urinary F2-isoprostanes using novel multidimensional solid-phase extraction and LC-MS/MS
Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan Published, JLR Papers in Press, January 10, 2007.
1 To whom correspondence should be addressed. e-mail: bozhang{at}fukuoka-u.ac.jp
F2-isoprostanes (F2-iPs), established markers of oxidative stress, exist as four sets of regioisomers. Simultaneous and specific determination of F2-iPs can be achieved by liquid chromatography-tandem mass spectrometry (LC-MS/MS). We developed novel methods for urine sample preparation and HPLC to control matrix-related ion suppression effects in the LC-MS/MS analysis of F2-iPs. A selective solid-phase extraction (SPE) wash protocol was developed with an Oasis HLB (hydrophilic-lipophilic balance) SPE cartridge using an elution profile of [3H]8-iso-prostaglandin (PG)F2
Supplementary key words liquid chromatography-tandem mass spectrometry urine ion suppression effects buffer-free HPLC sample preparation iPF2
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||